136 related articles for article (PubMed ID: 3535930)
1. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors.
Deeg HJ; Self S; Storb R; Doney K; Appelbaum FR; Witherspoon RP; Sullivan KM; Sheehan K; Sanders J; Mickelson E
Blood; 1986 Dec; 68(6):1363-8. PubMed ID: 3535930
[TBL] [Abstract][Full Text] [Related]
2. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients.
Storb R; Doney KC; Thomas ED; Appelbaum F; Buckner CD; Clift RA; Deeg HJ; Goodell BW; Hackman R; Hansen JA; Sanders J; Sullivan K; Weiden PL; Witherspoon RP
Blood; 1982 Feb; 59(2):236-46. PubMed ID: 7034811
[TBL] [Abstract][Full Text] [Related]
3. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.
Hill RS; Petersen FB; Storb R; Appelbaum FR; Doney K; Dahlberg S; Ramberg R; Thomas ED
Blood; 1986 Mar; 67(3):811-6. PubMed ID: 3511988
[TBL] [Abstract][Full Text] [Related]
4. Marrow transplant experience for children with severe aplastic anemia.
Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia.
Storb R; Prentice RL; Thomas ED; Appelbaum FR; Deeg HJ; Doney K; Fefer A; Goodell BW; Mickelson E; Stewart P
Br J Haematol; 1983 Dec; 55(4):573-85. PubMed ID: 6231046
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation experience for children with aplastic anemia.
Sanders JE; Whitehead J; Storb R; Buckner CD; Clift RA; Mickelson E; Appelbaum FR; Bensinger WI; Stewart PS; Doney K
Pediatrics; 1986 Feb; 77(2):179-86. PubMed ID: 3511444
[TBL] [Abstract][Full Text] [Related]
7. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.
Storb R; Thomas ED; Weiden PL; Buckner CD; Clift RA; Fefer A; Fernando LP; Giblett ER; Goodell BW; Johnson FL; Lerner KG; Neiman PE; Sanders JE
Blood; 1976 Dec; 48(6):817-41. PubMed ID: 11859
[TBL] [Abstract][Full Text] [Related]
8. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
[TBL] [Abstract][Full Text] [Related]
9. Treatment of aplastic anemia.
Loughran TP; Storb R
Hematol Oncol Clin North Am; 1990 Jun; 4(3):559-75. PubMed ID: 2193014
[TBL] [Abstract][Full Text] [Related]
10. Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine.
Deeg HJ; Shulman HM; Schmidt E; Yee GC; Thomas ED; Storb R
Transplantation; 1986 Nov; 42(5):497-501. PubMed ID: 3538535
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
Storb R; Etzioni R; Anasetti C; Appelbaum FR; Buckner CD; Bensinger W; Bryant E; Clift R; Deeg HJ; Doney K
Blood; 1994 Aug; 84(3):941-9. PubMed ID: 8043876
[TBL] [Abstract][Full Text] [Related]
12. Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia.
Niederwieser D; Pepe M; Storb R; Loughran TP; Longton G
Br J Haematol; 1988 May; 69(1):23-8. PubMed ID: 3289603
[TBL] [Abstract][Full Text] [Related]
13. Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?
Storb R; Prentice RL; Banaji M; Witherspoon RP; Sullivan KM; Stewart P; Sanders JE; Mason M; Doney K; Deeg J; Clift RA; Buckner CD; Appelbaum FR; Thomas ED
Blood; 1983 Apr; 61(4):672-5. PubMed ID: 6338970
[TBL] [Abstract][Full Text] [Related]
14. Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin.
Storb R; Weiden PL; Sullivan KM; Appelbaum FR; Beatty P; Buckner CD; Clift RA; Doney KC; Hansen J; Martin PJ
Blood; 1987 Jul; 70(1):116-21. PubMed ID: 3297199
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation for severe aplastic anemia.
Storb R; Champlin RE
Bone Marrow Transplant; 1991 Aug; 8(2):69-72. PubMed ID: 1933061
[TBL] [Abstract][Full Text] [Related]
16. Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia.
Storb R; Thomas ED; Buckner CD; Clift RA; Deeg HJ; Fefer A; Goodell BW; Sale GE; Sanders JE; Singer J; Stewart P; Weiden PL
Ann Intern Med; 1980 Jan; 92(1):30-6. PubMed ID: 6985782
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.
Storb R; Prentice RL; Sullivan KM; Shulman HM; Deeg HJ; Doney KC; Buckner CD; Clift RA; Witherspoon RP; Appelbaum FA; Sanders JE; Stewart PS; Thomas ED
Ann Intern Med; 1983 Apr; 98(4):461-6. PubMed ID: 6340576
[TBL] [Abstract][Full Text] [Related]
18. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
[TBL] [Abstract][Full Text] [Related]
19. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia.
Miyamura K; Kojima S; Takeyama K; Matsushita T; Fukuda M; Horibe K; Minami S; Morishima Y; Matsuyama K; Kodera Y
Bone Marrow Transplant; 1988 Sep; 3(5):457-61. PubMed ID: 3056553
[TBL] [Abstract][Full Text] [Related]
20. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
